This is most likely a vulvovaginal candidiasis (VVC) infection directly caused by Jardiance (empagliflozin), and you should treat it with a 7-14 day course of topical azole antifungal therapy.
Why This Is Happening
Jardiance is the culprit. SGLT2 inhibitors like empagliflozin (Jardiance) significantly increase the risk of genital mycotic infections by increasing urinary glucose excretion, which creates an ideal environment for fungal overgrowth 1. The FDA label explicitly warns that genital mycotic infections occur in 3.7-4.7% of patients on empagliflozin, with women at substantially higher risk (10-15%) 1. Patients with a history of chronic or recurrent genital infections are even more susceptible 1.
The failure of clobetasol (a potent topical steroid) to provide relief actually supports this diagnosis—steroids would worsen a fungal infection, not improve it. This 5-day duration with persistent symptoms despite steroid use is classic for an untreated fungal infection being inadvertently exacerbated.
Immediate Management
Start antifungal therapy now. Given that this patient has diabetes (even if controlled) and the infection has persisted for 5 days without improvement, this qualifies as "complicated VVC" requiring longer treatment duration 2.
Recommended Treatment Options:
First-line: 7-14 days of topical azole therapy (clotrimazole 1% cream 5g intravaginally daily for 7-14 days, OR miconazole 2% cream 5g intravaginally for 7 days) 2
Alternative: Fluconazole 150 mg orally, with a second dose 72 hours later 2
Why longer therapy? Women with diabetes—even controlled diabetes—don't respond as well to short-course therapies and require prolonged (7-14 days) conventional antimycotic treatment 2. The CDC guidelines specifically state that patients with underlying debilitating medical conditions like diabetes need extended treatment courses.
Critical Next Steps
- Discontinue clobetasol immediately - this is making things worse
- Consider obtaining vaginal cultures if symptoms don't improve with initial antifungal therapy, as 10-20% of recurrent VVC cases are caused by non-albicans species (particularly Candida glabrata) that are less responsive to conventional azoles 2
- Monitor and treat appropriately - most genital mycotic infections are mild to moderate and can be managed with topical antifungals without requiring SGLT2 inhibitor discontinuation 3
Important Considerations About Jardiance
Do NOT automatically discontinue Jardiance. The cardiovascular and renal benefits of SGLT2 inhibitors are substantial 3, 4, 5. Most genital mycotic infections can be successfully treated with antifungals while continuing the SGLT2 inhibitor 3. Only discontinue if:
- The infection becomes severe or recurrent despite appropriate antifungal treatment
- The patient develops necrotizing fasciitis (Fournier's gangrene)—though this is extremely rare and would present with fever, malaise, and severe pain 1
Red Flags to Watch For
Seek urgent evaluation if any of these develop:
- Fever or malaise
- Severe or worsening pain
- Spreading erythema beyond the genital area
- Systemic symptoms
These could indicate progression to necrotizing fasciitis (Fournier's gangrene), a rare but life-threatening complication requiring immediate broad-spectrum antibiotics, surgical debridement, and SGLT2 inhibitor discontinuation 1.
Follow-Up Plan
- Reassess in 3-5 days - if no improvement, obtain vaginal cultures to identify the specific Candida species
- If C. glabrata or other non-albicans species identified: Consider boric acid 600mg vaginal capsules daily for 2 weeks (70% eradication rate) 2
- Patient education: Counsel about the increased risk of genital infections with SGLT2 inhibitors and the importance of early treatment if symptoms recur
The bottom line: This is an SGLT2 inhibitor-associated genital mycotic infection requiring 7-14 days of topical azole therapy, not a dermatologic condition requiring steroids.